Co-Diagnostics, Inc

(NASDAQ:CODX)

Latest On Co-Diagnostics, Inc (CODX):

Date/Time Type Description Signal Details
2023-05-12 07:50 ESTNewsCo-Diagnostics, Inc. (CODX) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 18:15 ESTNewsCo-Diagnostics GAAP EPS of -$0.20 beats by $0.03, revenue of $0.61M misses by $0.49MN/A
2023-05-11 03:27 ESTNewsCo-Diagnostics Q1 2023 Earnings PreviewN/A
2023-03-21 03:13 ESTNewsCo-Diagnostics hits 52-week low as H.C. Wainwright cuts ratingN/A
2023-03-17 07:15 ESTNewsCo-Diagnostics, Inc. (CODX) Q4 2022 Earnings Call TranscriptN/A
2023-03-16 16:11 ESTNewsCo-Diagnostics GAAP EPS of -$0.45 misses by $0.54, revenue of $34.22M misses by $4.1MN/A
2023-03-16 01:07 ESTNewsCo-Diagnostics FY 2022 Earnings PreviewN/A
2023-02-21 22:58 ESTNewsCo-Diagnostics Is Losing Millions Per Quarter, Don't Buy On Cash Reserves AloneN/A
2022-11-22 18:18 ESTNewsCo-Diagnostics: Awaiting Evidence Of Pivot From COVID-19N/A
2022-11-11 08:05 ESTNewsCo-Diagnostics GAAP EPS of -$0.04, revenue of $5.1MN/A
2022-11-11 08:04 ESTNewsCo-Diagnostics, Inc. (CODX) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 22:21 ESTNewsCo-Diagnostics Q3 2022 Earnings PreviewN/A
2022-09-07 16:21 ESTNewsCo-Diagnostics: Hold Thesis Remains Well IntactN/A
2022-08-13 09:57 ESTNewsCo-Diagnostics, Inc.'s (CODX) CEO Dwight Egan on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-12 00:45 ESTNewsCo-Diagnostics GAAP EPS of -$0.08 misses by $0.18, revenue of $5.02M misses by $13.98MN/A
2022-08-12 00:45 ESTNewsCo-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumesN/A
2022-08-12 00:45 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 07:50 ESTNewsCo-Diagnostics Q2 2022 Earnings PreviewN/A
2022-07-11 17:31 ESTNewsCo-Diagnostics spikes on shipments of monkeypox testN/A
2022-06-23 10:31 ESTNewsMonkeypox plays tick higher ahead of WHO emergency meetingN/A
2022-06-22 00:43 ESTNewsCo-Diagnostics: Well Priced, Long-Term Value Remains Too DistantN/A
2022-05-27 18:24 ESTNewsCo-Diagnostics extends gains on monkeypox test developmentN/A
2022-05-13 09:00 ESTNewsCo-Diagnostics GAAP EPS of $0.34 beats by $0.17, revenue of $22.7M beats by $1.53MN/A
2022-05-13 09:00 ESTNewsCo-Diagnostics up 11% in post market following quarterly top and bottom line beatsN/A
2022-05-13 09:00 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 21:26 ESTNewsCo-Diagnostics Q1 2022 Earnings PreviewN/A
2022-04-19 20:57 ESTNewsCo-Diagnostics' JV CoSara gets Indian regulatory clearance for hepatitis C viral load testN/A
2022-04-03 06:53 ESTNewsCo-Diagnostics: Where's Eikon?N/A
2022-03-25 18:17 ESTNewsCo-Diagnostics GAAP EPS of $1.23 beats by $0.13, revenue of $97.89M misses by $0.53MN/A
2022-03-25 18:17 ESTNewsCo-Diagnostics reports decline in 2021 net income; sets in line guidance for Q1N/A
2022-03-25 18:17 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-24 07:38 ESTNewsCo-Diagnostics FY 2021 Earnings PreviewN/A
2022-03-15 20:18 ESTNewsCo-Diagnostics announces $30M buyback programN/A
2022-02-04 02:27 ESTNewsCo-Diagnostics announces approval for Hep B test in IndiaN/A
2022-01-24 18:48 ESTNewsCo-Diagnostics: Swinging For The FencesN/A
2022-01-13 13:22 ESTNewsCo-Diagnostics JV CoSara receives clearance in India for HPV multiplex testN/A
2021-12-22 14:42 ESTNewsCo-Diagnostics to acquire all assets related to upcoming at-home/point-of-care platformN/A
2021-12-08 04:21 ESTNewsCo-Diagnostics partners with Tiicker to reach individual investorsN/A
2021-11-30 02:15 ESTNewsCo-Diagnostics up 6% as Omicron variant won't interfere with its COVID testsN/A
2021-11-11 23:39 ESTNewsCo-Diagnostics EPS beats by $0.17, beats on revenueN/A
2021-11-11 23:39 ESTNewsCo-Diagnostics offers full-year guidance above consensus; shares up 14% after-hoursN/A
2021-11-11 23:39 ESTNewsXPOF, CODX, AFIB and BYND among after hour moversN/A
2021-11-11 23:39 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q3 2021 Earning Conference Call - Earnings Call TranscriptN/A
2021-11-11 03:51 ESTNewsCo-Diagnostics Q3 2021 Earnings PreviewN/A
2021-11-05 03:36 ESTNewsCo-Diagnostics' Logix Smart COVID-19 2-gene test approved for use in UKN/A
2021-10-07 07:26 ESTNewsCo-Diagnostics’ JV gets regulatory nod in India for Dengue/Chikungunya Multiplex TestN/A
2021-09-24 01:42 ESTNewsCo-Diagnostics undergoes corporate rebranding to reflect growthN/A
2021-09-17 16:52 ESTNewsCoSara Diagnostics gets CDSCO clearance to manufacture and sell its Saragene kitsN/A
2021-08-19 03:57 ESTNewsWhy Co-Diagnostics Is A Solid Covid-19 PlayN/A
2021-08-13 11:14 ESTNewsCo-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q2 2021 Results - Earnings Call TranscriptN/A

About Co-Diagnostics, Inc (CODX):

Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.

CODX Quotes by TradingView

See Advanced Chart

General

  • Name Co-Diagnostics, Inc
  • Symbol CODX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 39
  • Fiscal Year EndDecember
  • IPO Date2017-07-12
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.codiagnostics.com
View More

Valuation

  • Trailing PE 12.2
  • Forward PE 7.69
  • Price/Sales (Trailing 12 Mt.) 7.2
  • Price/Book (Most Recent Quarter) 7.37
  • Enterprise Value Revenue 7.61
  • Enterprise Value EBITDA 14.4
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate $0.68
  • Profit Margin 59%
  • Operating Margin 51%
  • Return on Assets 51%
  • Return on Equity 100%
  • Revenue 47.52 million
  • Earnings Per Share $1.12
  • Revenue Per Share $2
  • Gross Profit 102543
  • Quarterly Earnings Growth 52559.1%
View More

Highlights

  • Market Capitalization 387.01 million
  • EBITDA 24.14 million
  • PE Ratio -1.02
  • Analyst Target Price $27
  • Book Value Per Share $1.87
View More

Share Statistics

  • Shares Outstanding 28.27 million
  • Shares Float 26.42 million
  • % Held by Insiders 652%
  • % Held by Institutions 33.01%
  • Shares Short 3.95 million
  • Shares Short Prior Month 4.99 million
  • Short Ratio 1.99
  • Short % of Float 14%
  • Short % of Shares Outstanding 14%
View More

Technicals

  • Beta -1.82
  • 52 Week High $29.99
  • 52 Week Low $6.81
  • 50 Day Moving Average 14.87
  • 200 Day Moving Average 12.87
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Co-Diagnostics, Inc (CODX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Co-Diagnostics, Inc (CODX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A$0.53$0.71-24.82%
2020-06-302020-08-13$N/A$0.43$0.65-33.85%
2020-03-312020-05-14$1.55 million-$0.05-$0.04-25%
2019-12-312020-03-30$N/A-$0.09-$0.09-5.88%
2019-09-302019-11-12$41434-$0.10-$0.08-33.33%
2019-06-302019-08-14$61574-$0.08-$0.06-45.45%
2019-03-312019-05-14$3400-$0.09-$0.08-12.5%
2018-12-312018-12-31$10823-$0.15-$0.13-15.38%
2018-09-302018-11-14$9696-$0.13
2018-06-302018-08-10$9696-$0.11
2018-03-312018-05-14$9696-$0.11
2017-12-312018-03-28$3000-$0.12
2017-09-302017-09-30$3000-$0.33

Co-Diagnostics, Inc (CODX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Research Development N/A N/A 400022 N/A 331027
Income Before Tax N/A N/A -1.07 million N/A -1.75 million
Selling General Administrative N/A N/A 1.73 million N/A 1.32 million
Gross Profit N/A N/A 1.07 million N/A 21069
Ebit N/A N/A -1.04 million N/A -1.65 million
Operating Income N/A N/A -1.08 million N/A -1.65 million
Income Tax Expense -2.91 million N/A N/A N/A N/A
Total Revenue N/A N/A 1.55 million N/A 41434
Cost of Revenue N/A N/A 481740 N/A 20365
Total Other Income Expense Net N/A N/A 9181 N/A -97679
Net Income From Continuing Operations N/A N/A -1.07 million N/A -1.75 million
Net Income Applicable to Common Shares 15.73 million 12.64 million N/A -1.74 million -1.75 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -250370 N/A -72440
Change to Liabilities -1.19 million 1.75 million N/A 186 -34195
Total Cash Flow from Investing Activities -6.15 million -669420 N/A -38780 -96691
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 18.06 million N/A N/A
Change to Operating Activities 136538 -21853 N/A -279470 170453
Change in Cash N/A N/A 16.48 million N/A -1.31 million
Total Cash from Operating Activities 8.56 million 987069 -1.34 million -1.61 million -1.22 million
Depreciation N/A N/A 20748 N/A 17006
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A -488910 N/A -9120
Change to Account Receivables N/A N/A N/A N/A 2632
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income -2.62 million 432860 N/A 644759 477259
Capital Expenditures N/A N/A 100370 N/A 24251
Balance Sheet:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Total Liabailities N/A N/A 1.31 million N/A 477884
Total Stockholder Equity N/A N/A 19.17 million N/A 3.33 million
Other Current Liabilities 657925 N/A N/A N/A 4386
Total Assets N/A N/A 20.48 million N/A 3.81 million
Common Stock 28161 27991 N/A 17343 17337
Other Current Assets 2.91 million N/A N/A N/A N/A
Retained Earnings 4.7 million -13.4 million -26.03 million -24.97 million -23.15 million
Other Liabilities 60000 80000 N/A 150000 170000
Other Assets N/A N/A N/A N/A N/A
Cash N/A N/A 17.37 million N/A 2.54 million
Total Current Liabilities 1.81 million N/A 1.19 million N/A 307884
Other Stockholder Equity N/A N/A N/A N/A -26
Property, Plant & Equipment 538279 473376 N/A 196832 179746
Total Current Assets 51.95 million N/A 19.61 million N/A 3.08 million
Long Term Investments N/A N/A 593421 N/A 547685
Net Tangible Assets 52.78 million 33.36 million N/A 1.74 million 3.33 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory 10.73 million N/A 686078 N/A 17353
Accounts Payable 250465 N/A 132516 N/A 21760

Co-Diagnostics, Inc (CODX) Chart:

Co-Diagnostics, Inc (CODX) News:

Below you will find a list of latest news for Co-Diagnostics, Inc (CODX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Co-Diagnostics, Inc (CODX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-04-260.50CALL0 00TRUE00
2024-04-2610CALL0 00TRUE00
2024-04-261.50.05CALL0 70FALSE00
2024-04-2620.05CALL0 10FALSE00
2024-04-2630CALL0 00FALSE00
2024-04-263.50CALL0 00FALSE00
2024-04-260.50.05PUT0 20FALSE00
2024-04-2610.15PUT0 40FALSE00
2024-04-261.50PUT0 00TRUE00
2024-04-2620PUT0 00TRUE00
2024-04-2630PUT0 00TRUE00
2024-04-263.50PUT0 00TRUE00
2024-05-030.50CALL0 01211.66TRUE00
2024-05-0310CALL0 0799.14TRUE00
2024-05-031.50.15CALL0 450FALSE00
2024-05-0320.05CALL0 20FALSE00
2024-05-030.50PUT0 00FALSE00
2024-05-0310.15PUT0 270FALSE00
2024-05-031.50PUT0 0673.1TRUE00
2024-05-0320PUT0 0375.15TRUE00
2024-05-100.50CALL0 00TRUE00
2024-05-1010CALL0 0583.16TRUE00
2024-05-101.50CALL0 00FALSE00
2024-05-1020CALL0 00FALSE00
2024-05-100.50PUT0 00FALSE00
2024-05-1010.05PUT0 100FALSE00
2024-05-101.50PUT0 0520.63TRUE00
2024-05-1020PUT0 0563.25TRUE00
2024-05-170.50CALL0 0848.62TRUE00
2024-05-1710.2CALL0 161136.6TRUE00
2024-05-171.50CALL0 00FALSE00
2024-05-1720.05CALL0 9370FALSE00
2024-05-1730.05CALL0 1620FALSE00
2024-05-1740.05CALL0 440FALSE00
2024-05-1750CALL0 00FALSE00
2024-05-170.50PUT0 00FALSE00
2024-05-1710.05PUT0 750FALSE00
2024-05-171.50PUT0 0227.06TRUE00
2024-05-1720.83PUT0 278353.75TRUE00
2024-05-1730PUT0 0564.82TRUE00
2024-05-1740PUT0 0462.84TRUE00
2024-05-1750PUT0 01094.7TRUE00
2024-05-240.50CALL0 00TRUE00
2024-05-2410CALL0 00TRUE00
2024-05-241.50.05CALL0 70FALSE00
2024-05-2420CALL0 00FALSE00
2024-05-242.50CALL0 00FALSE00
2024-05-240.50PUT0 00FALSE00
2024-05-2410.05PUT0 200FALSE00
2024-05-241.50PUT0 00TRUE00
2024-05-2420PUT0 0407.36TRUE00
2024-05-242.50PUT0 0456.43TRUE00
2024-05-310.50CALL0 00TRUE00
2024-05-3110CALL0 00TRUE00
2024-05-311.50.15CALL0 20FALSE00
2024-05-3120CALL0 00FALSE00
2024-05-312.50CALL0 00FALSE00
2024-05-310.50PUT0 00FALSE00
2024-05-3110PUT0 00FALSE00
2024-05-311.50PUT0 0375.14TRUE00
2024-05-3120PUT0 0456.3TRUE00
2024-05-312.50PUT0 0410.88TRUE00
2024-06-2110CALL0 0115.24TRUE00
2024-06-2120CALL0 00FALSE00
2024-06-2130CALL0 00FALSE00
2024-06-2140CALL0 00FALSE00
2024-06-2110.1PUT0 10FALSE00
2024-06-2120PUT0 0147.07TRUE00
2024-06-2130PUT0 0156.21TRUE00
2024-06-2140PUT0 0295.61TRUE00
2024-08-1610.35CALL6 3114.27TRUE0.350
2024-08-1620.1CALL0 10850FALSE00
2024-08-1630.05CALL0 70FALSE00
2024-08-1640.05CALL0 210FALSE00
2024-08-1650CALL0 00FALSE00
2024-08-1610.1PUT0 2670.93FALSE00
2024-08-1620.89PUT0 3595.76TRUE00
2024-08-1630PUT0 0137.75TRUE00
2024-08-1640PUT0 0217.68TRUE00
2024-08-1650PUT0 0322.54TRUE00
2024-11-1510.4CALL4 0100.31TRUE0.40
2024-11-1520.1CALL0 440FALSE00
2024-11-1530.05CALL0 10FALSE00
2024-11-1540CALL0 00FALSE00
2024-11-1510.15PUT0 5671.71FALSE00
2024-11-1520PUT0 064.43TRUE00
2024-11-1530PUT0 0129.53TRUE00
2024-11-1540PUT0 0294.59TRUE00
2025-01-1710.45CALL0 49894.19TRUE00
2025-01-1720.18CALL0 370386.8FALSE00
2025-01-1730.05CALL0 5970FALSE00
2025-01-1740.13CALL0 4500FALSE00
2025-01-1750.08CALL0 3870FALSE00
2025-01-1770.05CALL0 6860FALSE00
2025-01-1710.2PUT0 8278.91FALSE00
2025-01-1720.95PUT0 18759.14TRUE00
2025-01-1731.85PUT0 0145.36TRUE00
2025-01-1742.7PUT0 0146.1TRUE00
2025-01-1750PUT0 0170.07TRUE00
2025-01-1775.84PUT0 0195.3TRUE00

Latest CODX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$5.045
Jun 13, 2022 7:59 PM EST62$5.02
Jun 13, 2022 7:59 PM EST10$5.02
Jun 13, 2022 7:59 PM EST32$5.03
Jun 13, 2022 7:59 PM EST24$5.05

Co-Diagnostics, Inc (CODX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010741/0001493152-20-010741-index.htm
2017-02-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000017004539/0000000000-17-004539-index.htm
2017-04-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000017013810/0000000000-17-013810-index.htm
2017-05-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000017017494/0000000000-17-017494-index.htm
2017-06-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000017019457/0000000000-17-019457-index.htm
2018-08-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692415/000000000018026897/0000000000-18-026897-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000110465919006973/0001104659-19-006973-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000110465920013404/0001104659-20-013404-index.htm
2019-01-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000005/0001469709-19-000005-index.htm
2019-05-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000071/0001469709-19-000071-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000072/0001469709-19-000072-index.htm
2019-05-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000073/0001469709-19-000073-index.htm
2019-05-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000146970919000074/0001469709-19-000074-index.htm
2016-12-29DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793216014416/0001477932-16-014416-index.htm
2017-01-12DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692415/000147793217000164/0001477932-17-000164-index.htm
2017-03-31DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692415/000147793217001422/0001477932-17-001422-index.htm
2017-03-30DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692415/000147793217001424/0001477932-17-001424-index.htm
2017-04-28S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217002006/0001477932-17-002006-index.htm
2017-05-24S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217002536/0001477932-17-002536-index.htm
2017-05-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217002539/0001477932-17-002539-index.htm
2017-06-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217002732/0001477932-17-002732-index.htm
2017-06-09FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217002739/0001477932-17-002739-index.htm
2017-06-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217002758/0001477932-17-002758-index.htm
2017-06-23S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217002969/0001477932-17-002969-index.htm
2017-06-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217003023/0001477932-17-003023-index.htm
2017-07-10S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000147793217003231/0001477932-17-003231-index.htm
2017-07-118-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217003234/0001477932-17-003234-index.htm
2017-07-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217003236/0001477932-17-003236-index.htm
2017-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000147793217003264/0001477932-17-003264-index.htm
2017-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000147793217003272/0001477932-17-003272-index.htm
2017-07-13424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217003279/0001477932-17-003279-index.htm
2017-07-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217003297/0001477932-17-003297-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004007/0001477932-17-004007-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004009/0001477932-17-004009-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004011/0001477932-17-004011-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004013/0001477932-17-004013-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004015/0001477932-17-004015-index.htm
2017-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004017/0001477932-17-004017-index.htm
2017-08-2510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217004217/0001477932-17-004217-index.htm
2017-09-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004384/0001477932-17-004384-index.htm
2017-09-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217004581/0001477932-17-004581-index.htm
2017-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000147793217005611/0001477932-17-005611-index.htm
2017-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000147793217006143/0001477932-17-006143-index.htm
2018-03-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1692415/000147793218001468/0001477932-18-001468-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218005004/0001493152-18-005004-index.htm
2018-04-114/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218005057/0001493152-18-005057-index.htm
2018-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218005251/0001493152-18-005251-index.htm
2018-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218005684/0001493152-18-005684-index.htm
2018-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218006315/0001493152-18-006315-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315218006835/0001493152-18-006835-index.htm
2018-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218006942/0001493152-18-006942-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315218011230/0001493152-18-011230-index.htm
2018-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315218011357/0001493152-18-011357-index.htm
2018-08-14S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000149315218011879/0001493152-18-011879-index.htm
2018-09-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692415/000149315218012918/0001493152-18-012918-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218014138/0001493152-18-014138-index.htm
2018-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218014141/0001493152-18-014141-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315218015065/0001493152-18-015065-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315218015919/0001493152-18-015919-index.htm
2018-11-30PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218016927/0001493152-18-016927-index.htm
2018-12-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1692415/000149315218017374/0001493152-18-017374-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219000111/0001493152-19-000111-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219000974/0001493152-19-000974-index.htm
2019-02-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1692415/000149315219001278/0001493152-19-001278-index.htm
2019-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219001285/0001493152-19-001285-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219001402/0001493152-19-001402-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219002495/0001493152-19-002495-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1692415/000149315219004300/0001493152-19-004300-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219006157/0001493152-19-006157-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315219007113/0001493152-19-007113-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219009755/0001493152-19-009755-index.htm
2019-07-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219010319/0001493152-19-010319-index.htm
2019-08-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219011962/0001493152-19-011962-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315219012480/0001493152-19-012480-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315219013719/0001493152-19-013719-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315219016885/0001493152-19-016885-index.htm
2019-11-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219017799/0001493152-19-017799-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219017801/0001493152-19-017801-index.htm
2019-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219017803/0001493152-19-017803-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219017826/0001493152-19-017826-index.htm
2019-11-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315219018053/0001493152-19-018053-index.htm
2020-01-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220001137/0001493152-20-001137-index.htm
2020-01-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220001176/0001493152-20-001176-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220001966/0001493152-20-001966-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220002114/0001493152-20-002114-index.htm
2020-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220002743/0001493152-20-002743-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220003091/0001493152-20-003091-index.htm
2020-02-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220003154/0001493152-20-003154-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1692415/000149315220005305/0001493152-20-005305-index.htm
2020-04-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220006440/0001493152-20-006440-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220008745/0001493152-20-008745-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220008931/0001493152-20-008931-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220009671/0001493152-20-009671-index.htm
2020-06-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010549/0001493152-20-010549-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010551/0001493152-20-010551-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010553/0001493152-20-010553-index.htm
2020-06-045Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010556/0001493152-20-010556-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010695/0001493152-20-010695-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010696/0001493152-20-010696-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010697/0001493152-20-010697-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010698/0001493152-20-010698-index.htm
2020-06-084/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220010741/0001493152-20-010741-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220015523/0001493152-20-015523-index.htm
2020-10-23S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692415/000149315220019890/0001493152-20-019890-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692415/000149315220020339/0001493152-20-020339-index.htm
2020-11-0310-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692415/000149315220020357/0001493152-20-020357-index.htm
2020-11-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1692415/000149315220020363/0001493152-20-020363-index.htm
2020-11-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1692415/000149315220020365/0001493152-20-020365-index.htm
2019-02-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000153561019000066/0001535610-19-000066-index.htm
2020-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000153561020000007/0001535610-20-000007-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692415/000153561020000062/0001535610-20-000062-index.htm
2017-07-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1692415/999999999517001776/9999999995-17-001776-index.htm
2018-09-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1692415/999999999518002306/9999999995-18-002306-index.htm
2020-11-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1692415/999999999520003090/9999999995-20-003090-index.htm
2017-07-11CERTNASCertification by the Nasdaq Stock Market approving securities for listinghttps://www.sec.gov/Archives/edgar/data/1692415/999999999717007475/9999999997-17-007475-index.htm

Co-Diagnostics, Inc (CODX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Co-Diagnostics, Inc (CODX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 652%
Institutional Ownership: 3301%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-06America 2030 Capital, LLC10% Share HolderSell1,134,898.000.0111,348.980.00https://www.sec.gov/Archives/edgar/data/1692415/000146970919000072/0001469709-19-000072-index.htm
2020-05-20Eugene DurenardDirectorSell25,000.0018.40460,000.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010698/0001493152-20-010698-index.htm
2020-05-26Eugene DurenardDirectorSell25,000.0018.26456,500.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010698/0001493152-20-010698-index.htm
2017-12-13-07:00REED L BENSONCFO and SecretarySell17,792.004.6582,732.800.00https://www.sec.gov/Archives/edgar/data/1692415/000147793217006143/0001477932-17-006143-index.htm
2020-05-19RICHARD S SERBINDirectorSell25,000.0018.50462,500.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010697/0001493152-20-010697-index.htm
2020-05-28RICHARD S SERBINDirectorSell7,500.0018.00135,000.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010697/0001493152-20-010697-index.htm
2020-05-28RICHARD S SERBINDirectorSell17,500.0018.03315,525.000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010697/0001493152-20-010697-index.htm
2018-07-18America 2030 Capital, LLC10% Share HolderSell1,134,897.000.0111,348.971,134,898.00https://www.sec.gov/Archives/edgar/data/1692415/000146970919000072/0001469709-19-000072-index.htm
2017-12-13-07:00REED L BENSONCFO and SecretarySell2,776.004.6512,908.4017,792.00https://www.sec.gov/Archives/edgar/data/1692415/000147793217006143/0001477932-17-006143-index.htm
2018-04-09Brent SatterfieldChief Science OfficerBuy2,400.004,920.0011,808,000.002,272,198.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218005004/0001493152-18-005004-index.htm
2018-04-16Brent SatterfieldChief Science OfficerBuy500.001.94970.002,272,698.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218005251/0001493152-18-005251-index.htm
2018-04-23Brent SatterfieldChief Science OfficerBuy500.002.021,010.002,273,198.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218005684/0001493152-18-005684-index.htm
2018-05-03Brent SatterfieldChief Science OfficerBuy500.001.91955.002,273,695.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218006315/0001493152-18-006315-index.htm
2018-05-11Brent SatterfieldChief Science OfficerBuy1,305.001.822,375.102,275,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315218006942/0001493152-18-006942-index.htm
2020-05-20Eugene DurenardDirectorBuy25,000.000.7117,750.0025,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010551/0001493152-20-010551-index.htm
2020-05-20Eugene DurenardDirectorBuy25,000.003.9699,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010551/0001493152-20-010551-index.htm
2020-05-19RICHARD S SERBINDirectorBuy25,000.000.7117,750.0025,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220009671/0001493152-20-009671-index.htm
2020-05-28RICHARD S SERBINDirectorBuy25,000.003.9699,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1692415/000149315220010696/0001493152-20-010696-index.htm